Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441103
Status:
COMPLETED
Last Update Posted:
2014-07-09
First Post:
2007-02-26
Brief Title:
A Study to Evaluate Rebif New Formulation Interferon-beta-1a in Relapsing Remitting Multiple Sclerosis
Sponsor:
Merck KGaA Darmstadt Germany
Organization:
Merck KGaA Darmstadt Germany
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Multiple Sclerosis Relapsing-Remitting |
Keywords:
| Name | View |
|---|---|
| Subjects with relapsing remitting multiple sclerosis | View |